C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/52 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 31/5415 (2006.01) C07D 239/34 (2006.01) C07D 239/60 (2006.01) C07D 261/14 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 405/04 (2006.01) C07D 405/06 (2006.01) C07D 413/12 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2652636
Endothelin receptor antagonist nitroderivatives of general formula (I) having an improved pharmacological activity compared with their parent compounds. They can be employed for treating or preventing endothelial-related disorders, renal, pulmonary, cardiac and vascular diseases, and inflammatory processes.
La présente invention porte sur des dérivés nitro, antagonistes de récepteur d'endothéline, de formule générale (I) : formule (I), d'activité pharmacologique améliorée par rapport à leurs composés parents. Ils peuvent être employés dans le traitement prophylactique ou thérapeutique de troubles de type endothélial, de maladies rénales, pulmonaires, cardiaques et vasculaires, et de processus inflammatoires.
Almirante Nicoletta
Biondi Stefano
Ongini Ennio
Gowling Lafleur Henderson Llp
Nicox S.a.
LandOfFree
Nitrated heterocyclic compounds as endothelin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrated heterocyclic compounds as endothelin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrated heterocyclic compounds as endothelin receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2077707